Dihydromethysticin

CAS No. 19902-91-1

Dihydromethysticin( (+)-Dihydromethysticin )

Catalog No. M23898 CAS No. 19902-91-1

Dihydromethysticin is a kavalactone found in Piper methysticum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 162 In Stock
5MG 144 In Stock
10MG 217 In Stock
25MG 330 In Stock
50MG 461 In Stock
100MG 644 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydromethysticin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydromethysticin is a kavalactone found in Piper methysticum.
  • Description
    Dihydromethysticin is a kavalactone found in Piper methysticum. It has marked activity on the induction of CYP3A23.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (+)-Dihydromethysticin
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP3A23
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19902-91-1
  • Formula Weight
    276.28
  • Molecular Formula
    C15H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble;Ethanol:Soluble
  • SMILES
    O=C1C=C(OC)C[C@H](CCC2=CC=C(OCO3)C3=C2)O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ma Y, et al. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metab Dispos. 2004 Nov;32(11):1317-24.
molnova catalog
related products
  • ε-?Viniferin

    ε-Viniferin a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.

  • CYP1B1-IN-7

    CYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds.

  • 2,3-dihydrothieno-Th...

    2,3-dihydrothieno-Thiadiazole Carboxylate is a CYP450 (CYP2E1 and CYP2B4) inhibitor.